GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Jia Jie Biomedical Co 4109.TWO · TWD

Consumer Staples · Taipei Exchange · 🇹🇼 Taiwan

Compare

10.20

+0.99%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 485.4m

FY2016FY2025

Net income

TWD 50.3m

FY2016FY2025

Free cash flow

−TWD 64.2m

FY2016FY2025

Shareholders' equity

TWD 1.68bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 485.4mTWD 537.1mTWD 332.8mTWD 317.7mTWD 242.5mTWD 270.3mTWD 343.1mTWD 402.0mTWD 521.8mTWD 626.1m
Gross profitTWD 150.3mTWD 173.3mTWD 117.6mTWD 116.5mTWD 83.8mTWD 41.7mTWD 88.0mTWD 109.8mTWD 131.8mTWD 223.0m
Research and developmentTWD 6.7mTWD 6.5mTWD 9.3mTWD 8.9mTWD 3.6mTWD 165,000TWD 1.9mTWD 2.1mTWD 3.3mTWD 11.5m
Operating incomeTWD 696,000TWD 33.2m−TWD 66.5m−TWD 14.4m−TWD 1.2m−TWD 48.3m−TWD 22.6m−TWD 42.3m−TWD 59.2mTWD 37.8m
Net incomeTWD 50.3mTWD 211.4mTWD 144.1m−TWD 5.5mTWD 5.3m−TWD 31.9m−TWD 24.5mTWD 2.5m−TWD 232.1mTWD 11.6m
Diluted earnings per share0.512.141.62-0.060.06-0.36-0.400.03-2.350.12

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 1.89bnTWD 1.48bnTWD 1.41bnTWD 1.00bnTWD 1.02bnTWD 989.4mTWD 855.8mTWD 1.12bnTWD 1.32bnTWD 1.65bn
Total liabilitiesTWD 174.9mTWD 123.1mTWD 342.7mTWD 80.0mTWD 86.5mTWD 81.4mTWD 160.9mTWD 404.4mTWD 621.6mTWD 684.9m
Debt——————TWD 62.8mTWD 299.0mTWD 507.8mTWD 562.7m
Shareholders' equityTWD 1.68bnTWD 1.33bnTWD 1.05bnTWD 898.0mTWD 907.9mTWD 909.3mTWD 695.4mTWD 707.6mTWD 690.0mTWD 935.1m
Shares outstanding99m99m89m89m89m89m61m99m99m99m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 21.3mTWD 44.3m−TWD 4.5m−TWD 8.8mTWD 4.4mTWD 27.1mTWD 24.7m−TWD 13.1m−TWD 13.7m−TWD 76.5m
Capital spending−TWD 85.5m−TWD 19.6m−TWD 8.6m−TWD 17.9m−TWD 1.5m−TWD 1.6m−TWD 3.1m−TWD 8.3m−TWD 3.5m−TWD 32.1m
Free cash flow−TWD 64.2mTWD 24.7m−TWD 13.1m−TWD 26.6mTWD 2.9mTWD 25.5mTWD 21.7m−TWD 21.4m−TWD 17.2m−TWD 108.6m
Dividends paid−TWD 59.4m−TWD 49.4m——————−TWD 6.2m−TWD 14.9m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 133.0mTWD 135.1mTWD 133.8mTWD 112.7mTWD 106.0mTWD 132.9mTWD 130.5mTWD 95.4m
Gross profitTWD 36.0mTWD 38.2mTWD 33.1mTWD 31.4mTWD 38.0mTWD 47.8mTWD 42.7mTWD 30.9m
Operating income−TWD 279,000TWD 2.8m−TWD 10.1m−TWD 3.9mTWD 3.9mTWD 10.8mTWD 10.6m−TWD 509,000
Net income−TWD 52.8mTWD 18.4mTWD 27.3mTWD 10.2m−TWD 691,000TWD 13.5m−TWD 19.7mTWD 3.0m
Diluted earnings per share-0.530.190.280.10-0.010.14-0.200.03
Cash from operations−TWD 11.0mTWD 12.0mTWD 11.0m—−TWD 3.0mTWD 12.0mTWD 20.0m−TWD 20.0m
Capital spending−TWD 3.0m−TWD 5.0m−TWD 28.0m−TWD 28.0m−TWD 24.0m−TWD 4.0m−TWD 16.0m—
Free cash flow−TWD 14.0mTWD 7.0m−TWD 17.0m—−TWD 27.0mTWD 8.0mTWD 4.0m—
Total assetsTWD 1.88bnTWD 1.92bnTWD 1.89bnTWD 1.84bnTWD 1.83bnTWD 1.87bnTWD 1.48bnTWD 1.50bn
DebtTWD 65.6mTWD 70.0m——————
Shareholders' equityTWD 1.62bnTWD 1.67bnTWD 1.68bnTWD 1.65bnTWD 1.64bnTWD 1.64bnTWD 1.33bnTWD 1.36bn

Financial ratios

Data as of 1 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Gross margin31.0%32.3%35.4%36.7%34.5%15.4%—————
Operating margin12.4%42.1%44.1%-1.4%-0.4%-17.9%—————
Net margin10.4%39.4%43.3%-1.7%2.2%-11.8%—————
Return on equity3.0%15.9%13.8%-0.6%0.6%-3.5%—————
Return on assets2.7%14.3%10.2%-0.5%0.5%-3.2%—————
Free cash flow yield—6.0%0.4%0.9%0.6%3.0%4.2%————
Revenue growth-9.6%61.4%4.7%31.0%-10.3%-21.2%—————
Earnings growth-76.2%46.6%-2735.2%-202.4%-116.7%30.4%—————
Current ratio3.36x2.98x1.30x4.31x4.15x4.79x—————
Debt to equity——————0.09x0.42x0.74x0.60x0.31x
Equity ratio89.1%89.8%74.1%89.4%88.9%91.9%—————
Interest coverage217.12x352.77x422.12x-40.42x-15.25x-67.79x—————
R&D as a share of sales1.4%1.2%2.8%2.8%1.5%0.1%—————
Buybacks as a share of market value—-11.0%0.0%0.0%0.0%-45.9%—————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue15.2%12.4%-4.8%
Operating income——-39.0%
Net income——2.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin31.7%33.3%31.3%31.4%
Operating margin3.3%-2.8%-4.4%-1.7%
Net margin25.6%23.9%17.1%3.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings30.410.110.6-239.0223.2-49.5-50.3—-9.1193.8
Price to sales3.14.04.64.14.95.83.63.44.03.6

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 24 Sept 2025.

FY2025FY2024
Paid in the year0.500.484
  • 1000-to-848.7829 reverse split · 21 Mar 2019
  • 1040-for-1000 split · 5 Sept 2017
  • 1050-for-1000 split · 12 Sept 2016
  • 1040.281-for-1000 split · 14 Sept 2015
  • 1038.531-for-1000 split · 24 Sept 2014
  • 1.03976-for-1 split · 24 Sept 2013

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.